National and Kapodistrian University of Athens
Μελέτη του πρωτεϊνικού προτύπου σε ειδικές ομάδες ασθενών με καρκίνο του μαστού
Abstract
dc:descriptionObjective: Male breast cancer (MBC) is a rare entity accounting for less than 1% of all malignancies in men. The aim of this thesis was to identify a panel of proteomic MBC biomarkers circulating in the human serum, that could be used to better understand MBC pathogenesis. This is the first study focusing on the elucidation of serum protein alterations in MBC, since serum represents an attractive, non-invasive source for biomarker discovery. Materials and Methods: In the present work, two-dimensional gel electrophoresis and matrix assisted laser desorption ionization-time of flight mass spectrometry were employed to detect differences in serum protein expression between patients with MBC and healthy controls. The differential expression of selected proteins was confirmed by Western Blot analysis or Enzyme Linked Immunosorbent Assay (ELISA). Functional relationships analysis of the differentially expressed proteins was performed using the STRING v.10 database. The PANTHER database was used to reveal the molecular function and signaling pathway associated with each identified protein. Results: A panel of differentially expressed serum proteins was identified, including proteins involved in the regulation of the cell cycle (e.g. cell division cycle 7-related protein kinase (CDC7), in mitochondrial function (e.g. mitochondrial aldehyde dehydrogenase (ALDH2) and dimethyladenosine transferase 1 (TFB1M), in lipid metabolism and transport (e.g. apolipoprotein A-I (APOA1) and E (APOE), in apoptosis and immune response (e.g. CD5 antigen-like (CD5L), clusterin (CLUS) and C-C motif chemokine 14 (CCL14), in transcription (e.g. protein SSX3 and signal transducer and activator of transcription 3 (STAT3), in invasion and metastasis (e.g. alpha-2-HS-glycoprotein (FETUA), in estrogen synthesis (aromatase (CP19A) and with other diverse biological roles (e.g. actin-related protein 2/3 complex subunit 4 (ARPC4), dual specificity mitogen-activated protein kinase kinase 4 (MP2K4), ectoderm-neural cortex protein 1 (ENC1), and matrix metalloproteinase-27 (MMP27). Conclusion: These findings provide valuable insight into the distinct clinicopathological features of MBC and indicate that select serum proteomic markers might help improve MBC management.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zografou, Eleni
- Ζωγράφου, Ελένη
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46741